# Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals

> **NCT05729503** · PHASE2 · WITHDRAWN · sponsor: **University of Calgary**

## Conditions studied

- Anxiety

## Interventions

- **DRUG:** Lidocaine 2% Injectable Solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05729503
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-05-06
- **Primary completion:** 2026-05-06
- **Final completion:** 2026-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No research capacity to support the project at this time.
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05729503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05729503, "Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05729503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*